Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the FD&C Act

9 organizations filed 11 public comments on Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the FD&C Act, at the Food and Drug Administration. The comment window closed 932d ago.

Commenters (9)

• Alliance for Pharmacy Compoundingtrade assoc.

  2 filings · confidence 85%
• National Community Pharmacists Associationtrade assoc.

  2 filings · confidence 97%
• Alliance for Natural Health USAtrade assoc.

  1 filing · confidence 85%
• American Academy of Dermatology Associationtrade assoc.

  1 filing · confidence 85%
• American Association of Naturopathic Physicianstrade assoc.

  1 filing · confidence 85%
• American Association of Naturopathic Physicians and Integrative Medicine Consortiumtrade assoc.

  1 filing · confidence 85%
• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• International Platinum Group Metals Associationtrade assoc.

  1 filing · confidence 85%
• Verrica Pharmaceuticals Inc.unverified attribution

  1 filing · confidence 70%